Docetaxel in combination carboplatin as first-line treatment of patients with inoperable, locally advanced or metastatic non-small cell lung cancer

被引：0
|
作者：
Barata, F
Camacho, E
Sousa, A
Costa, MS
Resende, R
Meleiro, A
Nogueira, F
Pereira, A
Canário, D
机构：
[1] Ctr Hosp Coimbra, Coimbra, Portugal
[2] Hosp Nossa Senhora Rosario, Barreiro, Portugal
[3] Hosp Univ Coimbra, Coimbra, Portugal
[4] Hosp Distrital Santarem, Santarem, Portugal
[5] Hosp Amato Lusitano, Castelo Branco, Portugal
[6] Hosp S Bernardo, Setubal, Portugal
[7] Hosp Egas Moniz, Lisbon, Portugal
[8] Hosp Distrital Fig Foz, Figueira Foz, Portugal
[9] Hosp Garcis Orta, Almada, Portugal
来源：
LUNG CANCER | 2005年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S235 / S235
页数：1
相关论文
共 50 条
  • [1] Docetaxel in combination with Gemcitabine as first-line treatment of patients with inoperable, locally advanced or metastatic non-small cell lung cancer (NSCLC)
    Barata, Fernando
    Sousa, Amelia
    Camacho, Elvira
    Costa, Marco S.
    Canario, Dolores
    Nogueira, Fernando
    Semedo, Eulalia
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 179 - 179
  • [2] Analysis of continuous first-line treatment with docetaxel and carboplatin for advanced non-small cell lung cancer
    Aoki, Takuya
    Ebihara, Akinori
    Yogo, Yurika
    Suemasu, Keiichi
    Sakamaki, Fumio
    [J]. ONCOLOGY LETTERS, 2014, 7 (06) : 1771 - 1777
  • [3] Pemetrexed for the first-line treatment of locally advanced or metastatic non-small cell lung cancer
    Fleeman, N.
    Bagust, A.
    McLeod, C.
    Greenhalgh, J.
    Boland, A.
    Dundar, Y.
    Dickson, R.
    Smith, C. Tudur
    Davis, H.
    Green, J.
    Pearson, M.
    [J]. HEALTH TECHNOLOGY ASSESSMENT, 2010, 14 : 47 - 53
  • [4] Gefitinib for the first-line treatment of locally advanced or metastatic non-small cell lung cancer
    Brown, T.
    Boland, A.
    Bagust, A.
    Oyee, J.
    Hockenhull, J.
    Dundar, Y.
    Dickson, R.
    Ramani, V. S.
    Proudlove, C.
    [J]. HEALTH TECHNOLOGY ASSESSMENT, 2010, 14 : 71 - 79
  • [5] Cisplatin plus docetaxel combination in the first-line treatment of metastatic non-small cell lung cancer
    Kaya, Ali Osman
    Buyukberber, Suleyman
    Dane, Faysal
    Isikdogan, Abdurrahman
    Ustaalioglu, Basak Oven
    Coskun, Ugur
    Yumuk, Perran Fulden
    Dogu, Gamze Gokoz
    Ozdemir, Nuriye Yildirim
    Sevinc, Alper
    Gumus, Mahmut
    Ozkan, Metin
    Yildiz, Ramazan
    Ozturk, Banu
    Yaman, Emel
    Benekli, Mustafa
    [J]. TUMORI JOURNAL, 2010, 96 (03): : 400 - 404
  • [6] PEMETREXED AND CARBOPLATIN VERSUS DOCETAXEL AND CARBOPLATIN AS FIRST-LINE TREATMENT FOR PATIENTS WITH ADVANCED, NON-SQUAMOUS, NON-SMALL CELL LUNG CANCER (NSCLC)
    Ganju, Vinod
    Pereira, Jose
    Kim, Joo-Hang
    Magallanes, Manuel
    Lee, Dae-Ho
    Wang, Jie
    Martinez, Luis
    Barraclough, Helen
    Van Kooten, Maximiliano
    Orlando, Mauro
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S417 - S418
  • [7] A study of weekly docetaxel and carboplatin as first-line chemotherapy for advanced non-small cell lung cancer
    Jiang, Haiping
    Zhang, Xiaochen
    Chen, Jing
    Zhang, Ling
    Xiong, Jianping
    Zhong, Lin
    Yu, Feng
    Qian, Jiong
    Yu, Lanfang
    Wang, Xiaoting
    Shi, Genming
    Deng, Jing
    Xu, Nong
    [J]. JOURNAL OF THORACIC DISEASE, 2014, 6 (02) : 79 - 85
  • [8] Docetaxel in combination with platinums (cisplatin or carboplatin) in advanced and metastatic non-small cell lung cancer
    Belani, CP
    [J]. SEMINARS IN ONCOLOGY, 2002, 29 (03) : 4 - 9
  • [9] Audit of gefitinib for the first-line treatment of locally advanced or metastatic non-small cell lung cancer in patients with EGFR mutation
    Douglas, R.
    Campbell, L.
    McAleese, J.
    Scullin, P.
    [J]. LUNG CANCER, 2013, 79 : S9 - S9
  • [10] Gemcitabine and carboplatin in the treatment of locally advanced and metastatic non-small cell lung cancer
    Leow, CH
    Liam, CK
    [J]. RESPIROLOGY, 2005, 10 (05) : 629 - 635
12345